Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients (Q40506672)

21 September 2017

1 reference

title

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients (English)

1 reference

adaptive radiation therapy

21 September 2017

0 references

0 references

author name string

Crook JM

1

1 reference

21 September 2017

Perry GA

2

1 reference

21 September 2017

Robertson S

3

1 reference

21 September 2017

Esche BA

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

21 September 2017

1 reference

21 September 2017

volume

45

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

624-31; discussion 631-2

1 reference

Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Prostate cancer. Radiation therapy for localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Local Control After Radiation for Prostatic Carcinoma: Significance and Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Significance of prostatic biopsies after radiation therapy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Radiation injury of the normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Proliferative cell nuclear antigen in postradiotherapy prostate biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Current Status of Prostate-Specific Antigen in the Radiotherapeutic Management of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

A pathologist's view of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Pathology of carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Therapy of prostatic cancer and histopathologic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Cytological grading of therapy-induced tumor regression in prostatic carcinoma: proposal of a new system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Predictors of survival after a positive post-irradiation prostate biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980054-5

7 January 2021

10.1016/S0090-4295(99)80054-5

Identifiers

DOI

1 reference

21 September 2017

1 reference